ARCHIVES

HHS System Of Misconduct investigation Not Suited For Clinical Trials, Broder Says

This article is from The Cancer Letter archive.

Vol. 20 No. 43 | November 11, 1994

Download PDF Visit The Full Archive

Related Articles

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

November 26, 2014

Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer

March 26, 2010

NCA Approves Draft of New Outstanding Investigator Grants

February 10, 1984

Patient’s Husband Had Idea to Use Avastin For Glioblastoma

April 3, 2009

FDA News: FDA Taking Comments on “First Generic” ANDA Process

November 21, 2014

Impeding Reagan Budget Cuts Feared By Cancer Program Advocates; DeVita Asks Parity With NIH

February 13, 1981